Gan & Lee Pharmaceuticals, a Chinese bio-pharmaceutical company backed by Qiming Venture Partners and other investors, is seeking a domestic IPO to raise RMB1.5 billion (US$221 million) two years after its first attempt failed. Beijing-based Gan & Lee was established in 1998 and focuses on researching and manufacturing recombinant human insulin and its analogues in […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.